Bioniche Life Sciences Inc. (BNC.TO)
-Toronto 0.34 
0.04(9.33%) 3:56PM EDT
| Prev Close: | 0.38 |
|---|
| Open: | 0.37 |
|---|
| Bid: | 0.33 |
|---|
| Ask: | 0.34 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.33 - 0.37 |
|---|
| 52wk Range: | 0.18 - 0.69 |
|---|
| Volume: | 114,657 |
|---|
| Avg Vol (3m): | 272,026 |
|---|
| Market Cap: | 35.54M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in CAD.
Headlines
- Bioniche Engages Evercore Partners to Assist in the Divestment of its Animal Health BusinessCNW Group(Mon, May 13)
- Bioniche Engages Evercore Partners to Assist in the Divestment of its Animal Health BusinessPR Newswire(Mon, May 13)
- Bioniche Life Sciences Inc. Reports Q3, Fiscal 2013 ResultsPR Newswire(Wed, May 8)
- Bioniche Life Sciences Inc. Reports Q3, Fiscal 2013 ResultsCNW Group(Wed, May 8)
- Bioniche Life Sciences Inc. Responds to Dissident Request for Shareholder MeetingPR Newswire(Sat, May 4)
- Bioniche Life Sciences Inc. Responds to Dissident Request for Shareholder MeetingCNW Group(Sat, May 4)
- Bioniche Life Sciences Inc. Acknowledges Request for Shareholder MeetingCNW Group(Fri, Apr 26)
- Bioniche Life Sciences Inc. Acknowledges Request for Shareholder MeetingPR Newswire(Fri, Apr 26)
- IIROC Trade Resumption - BNCCNW Group(Mon, Apr 22)
- Bioniche Life Sciences Inc. Responds to Letter from Former Biovail ExecutivesPR Newswire(Mon, Apr 22)
- Bioniche Life Sciences Inc. Responds to Letter from Former Biovail ExecutivesCNW Group(Mon, Apr 22)
- IIROC Trading Halt - BNCCNW Group(Mon, Apr 22)
- Bioniche Life Sciences Inc. Experiences Increased Trading ActivityCNW Group(Fri, Apr 19)
- Bioniche Life Sciences Inc. Experiences Increased Trading ActivityPR Newswire(Fri, Apr 19)
- Bioniche E. coli O157 Vaccine to be Used in an On-Farm Intervention Study in SwedenPR Newswire(Thu, Apr 18)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 1.27 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(0-00-31)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Bioniche Life Sciences Inc., a biopharmaceutical company, discovers, develops, manufactures, and markets proprietary products for human and animal health markets worldwide.
View More